A
Anne Mette Njaastad
Researcher at Oslo University Hospital
Publications - 8
Citations - 1168
Anne Mette Njaastad is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Deep vein & Randomized controlled trial. The author has an hindex of 5, co-authored 7 publications receiving 1043 citations.
Papers
More filters
Journal ArticleDOI
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
Tone Enden,Ylva Haig,Ylva Haig,Nils-Einar Kløw,Nils-Einar Kløw,Carl-Erik Slagsvold,Leiv Sandvik,Leiv Sandvik,Waleed Ghanima,Geir Hafsahl,Pål Andre Holme,Lars Olaf Holmen,Anne Mette Njaastad,Gunnar Sandbæk,Gunnar Sandbæk,Per Morten Sandset,Per Morten Sandset +16 more
TL;DR: This open-label, randomised controlled trial aimed to examine whether additional treatment with catheter-directed thrombolysis using alteplase reduced development of post-thrombotic syndrome in patients with a high proximal DVT and low risk of bleeding.
Journal ArticleDOI
Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency.
Tone Enden,Nils-Einar Kløw,Nils-Einar Kløw,Leiv Sandvik,Leiv Sandvik,Carl-Erik Slagsvold,Waleed Ghanima,Geir Hafsahl,Pål Andre Holme,Lars Olaf Holmen,Anne Mette Njaastad,Gunnar Sandbæk,Per Morten Sandset,Per Morten Sandset +13 more
TL;DR: After 6’months, additional CDT increased iliofemoral patency from 36% to 64%.
Journal ArticleDOI
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771).
Tone Enden,Leiv Sandvik,Nils-Einar Kløw,Geir Hafsahl,Pål Andre Holme,Lars Olaf Holmen,Waleed Ghanima,Anne Mette Njaastad,Gunnar Sandbæk,Carl-Erik Slagsvold,Per Morten Sandset +10 more
TL;DR: The aim of the CaVenT study is to investigate the role of adjunctive CDT by evaluating its clinical efficacy and safety compared with conventional treatment alone in patients with acute iliofemoral DVT and any documentation of improved functional outcome will have a significant impact on clinical practice.
Journal Article
[Catheter-directed thrombolysis of iliofemoral venous thrombosis].
Bernt Ly,Anne Mette Njaastad,Gunnar Sandbæk,Randi Solstrand,Antonio Rosales,Carl-Erik Slagsvold +5 more
TL;DR: Catheter-based thrombolysis is a safe and effective treatment of proximal deep venous thrombosis and might reduce the occurrence of postthrombotic syndrome compared to treatment with anticoagulation alone.
Journal ArticleDOI
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
Marianne S. Andresen,Irene Sandven,Cathrine Brunborg,Anne Mette Njaastad,Finn G. Strekerud,Michael Abdelnoor,Pål Smith,Ulrich Abildgaard +7 more
TL;DR: Despite a low mortality rate in this selected cohort, the recurrence rate and risk factors for recurrence were similar to findings reported in unselected populations.